Myomo Reports Third Quarter 2026 Financial and Operating Results

Record revenue of $12.3 million, increased 22% year over year Progress on four success pillars, including 54% of revenue from recurring patient sources Narrowing full-year revenue guidance to $46-47 million, at the upper end of previous guidance Conference call begins at 4:30pm Eastern time today BURLINGTON, Mass. (November 9, 2026) – Myomo, Inc. […]
Myomo to Attend the 17th Annual Craig Hallum Alpha Select Conference

BURLINGTON, Mass. (November 3, 2026) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced its participation at the 17th Annual Craig Hallum Alpha Select Conference being held Tuesday, November 17, 2026, at the Sheraton […]
Myomo to Report Third Quarter 2026 Financial Results on November 9

BURLINGTON, Mass. (November 2, 2026) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the third quarter ended September 30, 2026 on Monday, November 9, 2026 after […]
Myomo Appoints Mary-Katherine McClure as Chief Commercial Officer
BURLINGTON, MA. (October 12, 2026) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Mary-Katherine (“Katie”) McClure as Chief Commercial Officer effective October 12, 2026, succeeding Micah Mitchell, who will […]
Myomo to Present at the H.C. Wainwright 28th Annual Global Investment Conference

BURLINGTON, Mass. (September 1, 2026) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced its participation at the H.C. Wainwright 28th Annual Global Investment Conference being held September 14-16, 2026 at the Lotte Palace […]
Myomo Reports Second Quarter 2026 Financial and Operating Results

Revenue of $11.7 million, increased 21% year over year Four success pillars driving higher revenue growth and operating leverage Raising full year revenue guidance to $45-47 million Conference call begins at 4:30pm Eastern time today BURLINGTON, Mass. (August 5, 2026) – Myomo, Inc. (NYSE American: MYO)(“Myomo” or the “Company”), a wearable medical robotics […]
Myomo to Report Second Quarter 2026 Financial Results on August 5

BURLINGTON, Mass. (July 29, 2026) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the second quarter ended June 30, 2026 on Wednesday, August 5, 2026. Management will hold a conference call beginning at 4:30 p.m. Eastern time to review the results, provide […]
Myomo Announces Participation in iAccess Alpha Virtual Best Ideas Summer Investment Conference

BURLINGTON, Mass. (June 16, 2026) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced its participation in the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2026, taking place June 23–24, 2026. President and […]
Myomo Announces Participation in Upcoming Investor Conferences

BURLINGTON, Mass. (May 14, 2026) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced its participation in two upcoming investor conferences. On May 20, Myomo’s President and Chief Executive Officer Paul Gudonis and Chief […]
Myomo Appoints Joseph M. Manko to its Board of Directors

BURLINGTON, MA. (May 13, 2026) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Joseph M. (“Joe”) Manko Jr. as a director effective May 9, 2026, to serve until the 2027 […]